Small Animal Imaging (In Vivo) Market worth $1.55 Billion – 2017

The report "Global Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017", the global market is estimated at $789.4 million in 2012 and is poised to grow at a CAGR of 14.5% to reach $1,551.7 million by 2017.

Browse 117 tables and 20 figures spread through 269 pages combined with an in-depth TOC on "Small Animal Imaging (In Vivo) Market”
Early buyers will receive 10% customization on this report.

The global small animal imaging (in vivo) market is expected to grow at a CAGR of 14.5% from 2012 to 2017 and is classified into two types of imaging systems namely standalone and multimodal imaging technologies.

Talk to Our Research Analysts for More Info@

In addition, report covers different types of imaging reagents employed in small animal research studies such as nuclear imaging reagents, optical imaging reagents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents. With the diverse choice of imaging technologies, parameters such as disease model, cost, ease-of-use, accessibility to imaging agents, and utility of particular imaging modality, play crucial role in dictating researcher’s choice while purchasing an imaging system.

The global small animal imaging (in vivo) market is valued at $789.4 million in 2012 and is expected to grow at a CAGR of 14.5% over the next five years. Small animal in vivo imaging industry has experienced numerous technological advancements, changes in market due to change in government funding towards support for research across the globe and due to industry consolidation. It is projected that the trend of developing innovative products and enhancing existing products will continue in future to resolve the current challenges and meet the demanding needs of market.

Get The Sample Copy Of This Report:

Market shows growing preference towards hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. Technological advancements, growing adoption rate, rising application of functional imaging and increasing number of pharma companies are the major driving factors that are enhancing the growth of the market.

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan

Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @